Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Volumn 5, Issue 1, 2001, Pages 21-31

  Sader, H S ^a   Jones, R N ^a   Ballow, C H ^a   Biedenbach, D J ^a   Cered, R F ^a  

^a Department of Medicine Renal Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; QUINUPRISTIN-DALFOPRISTIN; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; GRAM POSITIVE COCCI; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; MULTIDRUG RESISTANCE; SOUTH AND CENTRAL AMERICA; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; GRAM-POSITIVE COCCI; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY; VIRGINIAMYCIN;

EID: 0035260949     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702001000100004     Document Type: Article

References (0)